The most common side effect of fenofibrate is abnormal liver test results, affecting about 8% of people who take it. Abdominal pain comes next at roughly 5%, followed by elevated liver enzymes and muscle enzyme changes at about 3% each. Most side effects are mild and manageable, but some require monitoring, especially in the first few months of treatment.
The Most Frequently Reported Side Effects
In placebo-controlled clinical trials, five adverse reactions occurred in 2% or more of people taking fenofibrate. Abnormal liver tests topped the list at 8%, making routine blood work a standard part of treatment. Abdominal pain occurred in about 5% of patients. Elevations in two specific liver enzymes (ALT and AST) each affected about 3% of patients, as did increases in creatine phosphokinase, an enzyme released when muscle tissue is stressed.
These numbers come from controlled trials where people taking fenofibrate were compared to people taking a placebo. So the rates reflect side effects that occurred more often with the drug than without it.
Digestive Symptoms
Beyond the abdominal pain captured in trial data, fenofibrate causes a range of digestive complaints. Nausea, vomiting, and stomach pain are considered less common but well-documented. Diarrhea and gas also occur and are generally considered bothersome rather than dangerous. Constipation is typically mild enough that it doesn’t require medical attention unless it persists.
Less frequently, people report bloating, indigestion, and loss of appetite. These symptoms often settle down as your body adjusts to the medication over the first few weeks. However, certain digestive symptoms deserve immediate attention: severe stomach pain with fever, nausea, or vomiting can signal gallbladder problems or pancreatitis. Pain that spreads to your back or worsens after eating is a particular red flag for pancreatitis.
Liver Effects
The 8% rate of abnormal liver tests sounds alarming, but context matters. Most of these elevations are mild and don’t cause symptoms. Actual drug-induced liver injury from fenofibrate is rare, occurring in only about 0.6% of patients. The threshold doctors watch for is when liver enzymes rise to more than five times the upper limit of normal, which is uncommon.
Signs of liver trouble you’d actually notice include pain in the upper right side of your abdomen, loss of appetite, nausea, unusually light-colored stool, dark urine, or yellowing of the skin or eyes. Your doctor will check liver enzymes through blood tests periodically, especially early in treatment, to catch elevations before they become a problem.
Muscle Pain and Weakness
Fenofibrate can cause muscle-related side effects ranging from mild aches to a rare but serious condition called rhabdomyolysis, where muscle tissue breaks down rapidly. With fenofibrate alone, the incidence of significant muscle problems is estimated at 0.1% to 0.5%. That risk climbs to 0.5% to 2.5% when fenofibrate is combined with a statin, which is a common pairing since both drugs target different aspects of cholesterol management.
If you notice unexplained muscle pain, tenderness, or weakness, especially if accompanied by dark-colored urine or fever, that warrants prompt medical evaluation. The 3% rate of elevated creatine phosphokinase seen in trials reflects subclinical muscle stress that shows up on blood work, often without any symptoms you can feel.
Kidney Function Changes
Fenofibrate commonly raises creatinine levels, a marker of kidney function. In the large FIELD trial involving people with diabetes, the average creatinine increase was about 12%, rising from 0.88 to 0.99 mg/dL. This increase is generally considered a lab artifact rather than true kidney damage, and it reverses once the medication is stopped.
That said, fenofibrate is not appropriate for people with severe kidney impairment. It’s contraindicated when kidney filtration rate drops below 30 mL/min, including people on dialysis. If you have moderate kidney issues, your doctor may adjust the dose or monitor your kidney function more frequently.
Gallstone Risk
Fibrate medications, including fenofibrate, increase cholesterol excretion into bile, which can raise the risk of gallstones. The overall risk is small, estimated at less than 1%. Symptoms of gallbladder problems include severe stomach pain, nausea, vomiting, and fever. If you’ve had gallbladder disease before, that’s worth mentioning to your prescriber.
Interactions With Blood Thinners
Fenofibrate can significantly amplify the effect of warfarin, a common blood thinner. It does this in two ways: it competes with warfarin for space on blood proteins, freeing up more active warfarin in the bloodstream, and it partially blocks the enzyme system responsible for breaking warfarin down. The combined result is a stronger anticoagulant effect and a higher bleeding risk.
If you take warfarin and start fenofibrate, your clotting levels (INR) should be checked within 48 to 72 hours of the first dose. Some clinicians preemptively reduce the warfarin dose by about 20% when adding fenofibrate, while others prefer to monitor and adjust as needed. Either way, frequent INR checks continue until your levels stabilize.
What to Watch for Early On
Most routine side effects like digestive discomfort and mild lab changes emerge within the first weeks to months of treatment. Constipation, gas, and mild nausea often resolve on their own. Liver enzyme elevations typically show up on scheduled blood tests rather than through symptoms you’d notice. Your doctor will generally order blood work before starting fenofibrate, then recheck within the first few months.
The serious side effects, including liver injury, rhabdomyolysis, pancreatitis, and gallbladder disease, are uncommon but can occur at any point during treatment. Knowing the warning signs (severe abdominal pain, unexplained muscle pain with dark urine, yellowing skin) helps you act quickly if they develop. For most people, fenofibrate is well tolerated over the long term, with the most common experience being mildly abnormal lab values that require monitoring but no change in how you feel day to day.